SK Biopharmaceuticals and twoXAR Sign Collaboration Agreement to Discover and Develop First-In-Class Treatments for Non-Small Cell Lung Cancer Read more
CASI Pharma In-Licenses Exclusive Worldwide Rights to Novel Anti-CD38 Monoclonal Antibody Program From Black Belt Therapeutics Read more
STC Biologics becomes the largest biologics CDMO within five miles of Cambridge, MA after addition of its new GMP manufacturing facility Read more
I-Mab Biopharma and WuXi Biologics Announce Long-term Strategic Manufacturing Partnership for Five Clinical and One Commercial Programs Read more
Recro Pharma Announces Six-Year Extension of License and Supply Agreement Between Teva and Recro Gainesville Read more
Gilead and insitro Announce Strategic Collaboration to Discover and Develop Novel Therapies for NASH Read more